Stock Price Quote

TITAN BIO-TECH LTD.

NSE : NABSE : 524717ISIN CODE : INE150C01011Industry : ChemicalsHouse : Private
BSE499.85-7.4 (-1.46 %)
PREV CLOSE ( ) 507.25
OPEN PRICE ( ) 508.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4533
TODAY'S LOW / HIGH ( )492.70 515.85
52 WK LOW / HIGH ( ) 230618
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 18-02 1992
Management Info
- Chairman Suresh Chand Singla - Managing Director
Registered Office

Address A - 902 A,R I I C O Industrial Area,Phase 3,
Bhiwadi,
Rajasthan-301019

Phone 011-27355742 / 27674615

Email hrd@titanbiotechltd.com

Website www.titanbiotechltd.com

Registrars Details
Beetal Financial & Computer Services (P) Ltd
Beetal House , 99 Mandangir,3rd Floor, Behind Local Shopping Centre,Near Dada Harsukhdas Mandir,New Delhi
Listing : BSE

NEWS

06Apr Titan Biotech informs about certificate
In accordance with Regulation 74 (5) of the SEBI (Depositories and Parti..
05Mar Titan Biotech informs about issue of d
Pursuant to Regulations 39(3) of SEBI (Listing Obligations and Disclosur..
13Feb Rail Vikas Nigam, Aurobindo Pharma and
Rail Vikas Nigam has been emerged as the Lowest Bidder (L1) from Madhya..
13Feb Titan Biotech soars on planning to acq
Titan Bio-Tech is currently trading at Rs. 520.00, up by 56.40 points or..
12Feb Titan Biotech to acquire stake in Tita
Titan Biotech is all set to acquire 33,90,510 partly paid up equity shar..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit73.84210.26
Gross Profit 99.41 281.17
Operating Profit 110.4314.63
Net Sales 459.791439.99

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Premier Explosives (BSE)
peergroup  2477.55 (3.14%)
M.Cap ( in Cr)2663.92
Balaji Amines (BSE)
peergroup  2280.50 (3.19%)
M.Cap ( in Cr)7389.05
Vinati Organics (BSE)
peergroup  1665.10 (2.65%)
M.Cap ( in Cr)17261.36
Deepak Nitrite (BSE)
peergroup  2514.35 (1.69%)
M.Cap ( in Cr)34293.98
Elantas Beck India (BSE)
peergroup  11354.85 (0.33%)
M.Cap ( in Cr)9001.76

Shareholding Pattern

PROMOTERS 55.88%
NON-INSTITUTION 43.9%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Titan Bio-Tech Ltd.

Titan Bio-Tech Ltd. was incorporated in the year 1992. Its today's share price is 499.85. Its current market capitalisation stands at Rs 413.06 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1439.99 Cr and Total Income of Rs.1459.42 Cr. The company's management includes Supriya Singla, Manju Singla, Raja Singla, Abhishek Agarwal, Rekha Dalmia, Rohit Jain, Suresh Chand Singla, Naresh Singla.

It is listed on the BSE with a BSE Code of 524717 , NSE with an NSE Symbol of and ISIN of INE150C01011. It's Registered office is at A - 902 A,R I I C O Industrial Area,Phase 3Bhiwadi-301019, Rajasthan. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are ANSK & Associates, Deepika Setia & Co, Sunita Agrawal & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.